<p>A 1:3 unmatched case-control study was conducted from February 15 to March 20, 2023, including 41 human cutaneous anthrax cases and 123 controls. Cases were defined as individuals with skin lesions evolving to a black eschar, while controls were neighbors without skin lesions. Data were collected using a structured interviewer-administered questionnaire adapted from the Centers for Disease Control (CDC) outbreak investigation tool. Epi Data 3.1 was used for data entry and SPSS version 20 for analysis. A binary logistic regression was fitted to identify factors for cutaneous anthrax infection. Adjusted odds ratios (AOR) with a 95% confidence interval (CI) were determined, and statistical significance was declared at a p-value &lt;0.05. The results were presented with texts, tables, graphs, and figures.&nbsp;</p>